Search research articles
Contact Us
Filters
Showing results (41-50 of 114) with videos related to
Page
of 12
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
June 8, 2007
Effects on neurite outgrowth and cell survival of a secreted fibroblast growth factor binding protein upregulated during spinal cord injury
Elena Tassi, Sharon Walter, Achim Aigner, et al.
Plos One
|
January 9, 2014
Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs
Narayan Shivapurkar, Louis M Weiner, John L Marshall, et al.
Plos One
|
April 19, 2016
Midkine and Pleiotrophin Concentrations in Amniotic Fluid in Healthy and Complicated Pregnancies
Youn Hee Jee, Yael Lebenthal, Piya Chaemsaithong, et al.
Scientific Reports
|
April 23, 2024
A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing
Anton Lahusen, Jierui Cai, Reinhold Schirmbeck, et al.
Cancer Research
|
November 19, 2004
The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells
Annabell Oh, Heinz-Joachim List, Ronald Reiter, et al.
International Wound Journal
|
September 14, 2013
Late failure of a split-thickness skin graft in the setting of homozygous factor V Leiden mutation: a case report and correlative animal model from the Wound Etiology and Healing (WE-HEAL) study
Victoria K Shanmugam, Sean McNish, Joanna Duncan, et al.
Cancer Genetics
|
November 21, 2017
Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
Eveline E Vietsch, Garrett T Graham, Justine N McCutcheon, et al.
The Journal of Biological Chemistry
|
July 18, 2002
Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types
Gerald E Stoica, Angera Kuo, Ciaran Powers, et al.
Cancer Genetics
|
November 19, 2018
Reprint of: Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
Eveline E Vietsch, Garrett T Graham, Justine N McCutcheon, et al.
Breast Cancer Research and Treatment
|
January 20, 2018
The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ
Virginie Ory, William B Kietzman, Jacob Boeckelman, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 114) with videos related to
Sort By:
Page
of 12
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
June 8, 2007
Effects on neurite outgrowth and cell survival of a secreted fibroblast growth factor binding protein upregulated during spinal cord injury
Elena Tassi, Sharon Walter, Achim Aigner, et al.
Plos One
|
January 9, 2014
Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs
Narayan Shivapurkar, Louis M Weiner, John L Marshall, et al.
Plos One
|
April 19, 2016
Midkine and Pleiotrophin Concentrations in Amniotic Fluid in Healthy and Complicated Pregnancies
Youn Hee Jee, Yael Lebenthal, Piya Chaemsaithong, et al.
Scientific Reports
|
April 23, 2024
A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing
Anton Lahusen, Jierui Cai, Reinhold Schirmbeck, et al.
Cancer Research
|
November 19, 2004
The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells
Annabell Oh, Heinz-Joachim List, Ronald Reiter, et al.
International Wound Journal
|
September 14, 2013
Late failure of a split-thickness skin graft in the setting of homozygous factor V Leiden mutation: a case report and correlative animal model from the Wound Etiology and Healing (WE-HEAL) study
Victoria K Shanmugam, Sean McNish, Joanna Duncan, et al.
Cancer Genetics
|
November 21, 2017
Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
Eveline E Vietsch, Garrett T Graham, Justine N McCutcheon, et al.
The Journal of Biological Chemistry
|
July 18, 2002
Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types
Gerald E Stoica, Angera Kuo, Ciaran Powers, et al.
Cancer Genetics
|
November 19, 2018
Reprint of: Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
Eveline E Vietsch, Garrett T Graham, Justine N McCutcheon, et al.
Breast Cancer Research and Treatment
|
January 20, 2018
The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ
Virginie Ory, William B Kietzman, Jacob Boeckelman, et al.
Page
of 12